Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Optimality in COVID-19 vaccination strategies determined by heterogeneity in human-human interaction networks

View ORCID ProfileBjörn Goldenbogen, Stephan O Adler, Oliver Bodeit, Judith AH Wodke, Ximena Escalera-Fanjul, Aviv Korman, Maria Krantz, Lasse Bonn, Rafael Morán-Torres, Johanna EL Haffner, Maxim Karnetzki, Ivo Maintz, Lisa Mallis, Hannah Prawitz, Patrick S Segelitz, Martin Seeger, View ORCID ProfileRune Linding, View ORCID ProfileEdda Klipp
doi: https://doi.org/10.1101/2020.12.16.20248301
Björn Goldenbogen
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Björn Goldenbogen
Stephan O Adler
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Bodeit
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
2Institut für Biochemie, Charité – Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith AH Wodke
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ximena Escalera-Fanjul
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aviv Korman
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Krantz
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lasse Bonn
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael Morán-Torres
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna EL Haffner
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxim Karnetzki
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivo Maintz
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Mallis
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Prawitz
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick S Segelitz
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Seeger
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
3Rewire Tx, Humboldt-Universität zu Berlin, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rune Linding
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
3Rewire Tx, Humboldt-Universität zu Berlin, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rune Linding
Edda Klipp
1Humboldt-Universität zu Berlin, Theoretical Biophysics, Invalidenstr. 42, 10115 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edda Klipp
  • For correspondence: edda.klipp@hu-berlin.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Interactions between humans cause transmission of SARS-CoV-2. We demonstrate that heterogeneity in human-human interactions give rise to non-linear infection networks that gain complexity with time. Consequently, targeted vaccination strategies are challenged as such effects are not accurately captured by epidemiological models assuming homogeneous mixing. With vaccines being prepared for global deployment determining optimality for swiftly reaching population level immunity in heterogeneous local communities world-wide is critical. We introduce a model that predicts the effect of vaccination into an ongoing COVID-19 outbreak using precision simulation of human-human interaction and infection networks. We show that simulations incorporating non-linear network complexity and local heterogeneity can enable governance with performance-quantified vaccination strategies. Vaccinating highly interactive people diminishes the risk for an infection wave, while vaccinating the elderly reduces fatalities at low population level immunity. Interestingly, a combined strategy is not better due to non-linear effects. While risk groups should be vaccinated first to minimize fatalities, significant optimality branching is observed with increasing population level immunity. Importantly, we demonstrate that regardless of immunization strategy non-pharmaceutical interventions are required to prevent ICU overload and breakdown of healthcare systems. The approach, adaptable in real-time and applicable to other viruses, provides a highly valuable platform for the current and future pandemics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Deutsche Forschungsgemeinschaft (DFG: Cluster of Excellence MATH+, TRR 175) and by the German Ministry of Education and Research (BMBF, Liver Systems Medicine (LiSyM) network grant) and by the People Programme (Marie Sklodowska-Curie Actions) of the European Unions Horizon 2020 Programme under REA grant agreement no. 813979 (Secreters). XEF is supported with a postdoctoral grant from CONACYT (CVU 420248). RL is supported by a BMBF GO-Bio initial grant 031B0988.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethical approval required

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used are included in the supplementary material.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Optimality in COVID-19 vaccination strategies determined by heterogeneity in human-human interaction networks
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Optimality in COVID-19 vaccination strategies determined by heterogeneity in human-human interaction networks
Björn Goldenbogen, Stephan O Adler, Oliver Bodeit, Judith AH Wodke, Ximena Escalera-Fanjul, Aviv Korman, Maria Krantz, Lasse Bonn, Rafael Morán-Torres, Johanna EL Haffner, Maxim Karnetzki, Ivo Maintz, Lisa Mallis, Hannah Prawitz, Patrick S Segelitz, Martin Seeger, Rune Linding, Edda Klipp
medRxiv 2020.12.16.20248301; doi: https://doi.org/10.1101/2020.12.16.20248301
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Optimality in COVID-19 vaccination strategies determined by heterogeneity in human-human interaction networks
Björn Goldenbogen, Stephan O Adler, Oliver Bodeit, Judith AH Wodke, Ximena Escalera-Fanjul, Aviv Korman, Maria Krantz, Lasse Bonn, Rafael Morán-Torres, Johanna EL Haffner, Maxim Karnetzki, Ivo Maintz, Lisa Mallis, Hannah Prawitz, Patrick S Segelitz, Martin Seeger, Rune Linding, Edda Klipp
medRxiv 2020.12.16.20248301; doi: https://doi.org/10.1101/2020.12.16.20248301

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (497)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (220)
  • Epidemiology (5776)
  • Forensic Medicine (3)
  • Gastroenterology (223)
  • Genetic and Genomic Medicine (889)
  • Geriatric Medicine (89)
  • Health Economics (235)
  • Health Informatics (778)
  • Health Policy (401)
  • Health Systems and Quality Improvement (259)
  • Hematology (108)
  • HIV/AIDS (188)
  • Infectious Diseases (except HIV/AIDS) (6612)
  • Intensive Care and Critical Care Medicine (398)
  • Medical Education (120)
  • Medical Ethics (29)
  • Nephrology (94)
  • Neurology (864)
  • Nursing (46)
  • Nutrition (145)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (268)
  • Oncology (521)
  • Ophthalmology (169)
  • Orthopedics (44)
  • Otolaryngology (108)
  • Pain Medicine (49)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (258)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (998)
  • Public and Global Health (2273)
  • Radiology and Imaging (382)
  • Rehabilitation Medicine and Physical Therapy (176)
  • Respiratory Medicine (315)
  • Rheumatology (111)
  • Sexual and Reproductive Health (85)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (35)
  • Urology (42)